Trade Summary

5 days ago, Apuli Maricel, serving as Chief Accounting Officer at Bridgebio Pharma, Inc. (BBIO), sold 510 shares at $74.31 per share, for a total transaction value of $37,898.00. Following this transaction, Apuli Maricel now holds 123,945 shares of BBIO.

The trade was executed on Tuesday, February 17, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 18, 2026, 1 day after the trade was made.

Bridgebio Pharma, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.